Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Kagan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Applied Animal Welfare Science : JAAWS|October 17, 2018
What Is the Future for Zoos and Aquariums?Ron Kagan, Stephanie Allard, Scott Carter
Journal of Applied Animal Welfare Science : JAAWS|October 7, 2015
A Universal Animal Welfare Framework for ZoosRon Kagan, Scott Carter, Stephanie Allard
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilizationRon Kagan, Mark Winters, Thomas Merigan, et al.
Drug Discovery Today|January 28, 2003
Structural pharmacogenomics, drug resistance and the design of anti-infective super-drugsEdward T Maggio, Mark Shenderovich, Ron Kagan, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibilityGeorge L Melikian, Soo-Yon Rhee, Jonathan Taylor, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L Melikian, Soo-Yon Rhee, Vici Varghese, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Applied Animal Welfare Science : JAAWS|October 17, 2018
What Is the Future for Zoos and Aquariums?Ron Kagan, Stephanie Allard, Scott Carter
Journal of Applied Animal Welfare Science : JAAWS|October 7, 2015
A Universal Animal Welfare Framework for ZoosRon Kagan, Scott Carter, Stephanie Allard
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 genotypic resistance in a clinical database correlates with antiretroviral utilizationRon Kagan, Mark Winters, Thomas Merigan, et al.
Drug Discovery Today|January 28, 2003
Structural pharmacogenomics, drug resistance and the design of anti-infective super-drugsEdward T Maggio, Mark Shenderovich, Ron Kagan, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibilityGeorge L Melikian, Soo-Yon Rhee, Jonathan Taylor, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L Melikian, Soo-Yon Rhee, Vici Varghese, et al.
Pageof 1